Ask AI
LIBRETTO-432
LIBRETTO-432: Phase III Trial of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion–Positive NSCLC

Released: June 15, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: June 15, 2026